Brind.
  1. The GENIUS Act has introduced a government-sanctioned alternative for Bitcoin adoption, driven by capital controls and currency depreciation in multiple countries.
  2. Trump signed the GENIUS Act, leading to SEC guidance and banks showing interest in stablecoin offerings.
  3. Following the GENIUS Act, key figures like Peter Thiel and companies such as Coinbase and Circle are positioning themselves to benefit from stablecoin regulatory clarity.

MEI Pharma plans to use net proceeds to buy Litecoin, appoint Charlie Lee, and utilize GSR for crypto reserves following the GENIUS Act.

1 report, 1 independent Updated Jul 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

MEI Pharma plans to use net proceeds to buy Litecoin, appoint Charlie Lee, and utilize GSR for crypto reserves following the GENIUS Act.

Who's involved

What this event is mainly about
MEI Pharma (United States)Charlie Lee

Keep exploring

Part of

Following the GENIUS Act, key figures like Peter Thiel and companies such as Coinbase and Circle are positioning themselves to benefit from stablecoin regulatory clarity. All 2 developments

Within The GENIUS Act has introduced a government-sanctioned alternative for Bitcoin adoption, driven by capital controls and currency depreciation in multiple countries.

The entities involved

Coverage

Newest first; wire copies grouped
  • CoinDeskLitecoin Surges 10%; Will $100M Bet by Nasdaq-Listed Company Fuel a Larger Rally? Litecoin (LTC) jumped 10% on Wednesday, extending its July rally, as a little-known biotech firm unveiled plans to ra